How many insider declarations has Phillips Gary M. filed?

Phillips Gary M. has filed 3 public insider declarations with SEC (Form 4).

What is Phillips Gary M.'s role?

Phillips Gary M.'s reported role is not specified by the regulator across the filings.

Which companies does Phillips Gary M. report trades for?

Phillips Gary M. reports trades for 2 companies, including Aldeyra Therapeutics, Inc..

← Executives ★ Sign in to follow

PG

Phillips Gary M.

·SEC (Form 4)

Aldeyra Therapeutics, Inc.Mallinckrodt plc

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Browse the complete record of transactions filed by Phillips Gary M.. Officer active across 2 companies, notably Aldeyra Therapeutics, Inc.. Aggregated, 3 disclosures have been published. Activity tracked since 7 September 2023. The latest transaction was disclosed on 7 September 2023 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.

Companies and markets linked to Phillips Gary M.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Aldeyra Therapeutics, Inc. (US)Mallinckrodt plc (US)

申报3 总计

◇

Phillips Gary M.

Director高管2023年9月7日Aldeyra Therapeutics, Inc.

US$3,00119SEC ↗

5,437 股@ US$0.552100.0% 占其流量Common StockSEC:0000950170-23-047497:0

●

Phillips Gary M.

Sr. VP, Chief Strategy Officer高管2016年1月2日Mallinckrodt plc

0SEC ↗

421 股Ordinary SharesSEC:0001445064-16-000192:0

◆

Phillips Gary M.

Sr. VP, Chief Strategy Officer高管2016年1月4日Mallinckrodt plc

0SEC ↗

4,270 股Ordinary SharesSEC:0001445064-16-000192:1

3 条申报中的 3 条

InsidersTradesSigma

← Executives ★ Sign in to follow

PG

Phillips Gary M.

·SEC (Form 4)

Aldeyra Therapeutics, Inc.Mallinckrodt plc

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Browse the complete record of transactions filed by Phillips Gary M.. Officer active across 2 companies, notably Aldeyra Therapeutics, Inc.. Aggregated, 3 disclosures have been published. Activity tracked since 7 September 2023. The latest transaction was disclosed on 7 September 2023 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.